Modified neomycin prepared by the ionic coupling on xanthan with an activity of 380 UI/mg was characterized in regard to its in vitro and in vivo release rate and therapeutic action with artificial tear eluent. The dynamic system in vitro release showed that after 4 h, there appears a "zero-order" kinetic. Ophthalmic inserts were prepared from modified neomycin and they are used in treating bacterial conjunctivitis. Sterilization of the conjunctival sac is obtained 12 h after insert administration.
References
1.
Beldie, C., S. Dumitriu, N. Aelenei, M. Popa, M.I. Popa and D. Dumitriu.1989. "Bioactive Polymers LX. Kinetics of Delayed Release Neomycin-Xanthan Complex," Biomaterials, 10:622.
2.
Bloomfield, S.E., T. Miyata, M.W. Dunn, N. Bueser, K.H. Stenzel and A.L. Rubin.1978. "Soluble Gentamycin Ophthalmic Inserts as a Drug Delivery System," Arch. Ophthalmol. , 96:885.
3.
Bruck, S.D.1983. "Pharmacological Basis of Controlled Drug Delivery, in Controlled Drug Delivery," Basic Concepts, Vol. 1. S. D. Bruck, ed. Boca Raton: CRC Press, Inc., p. 1.
4.
Dumitriu, S. , M. Popa, P. Vancea and D. Costin.1988. "Polycomponent Ophthalmic Inserts with Polysaccharide Support," J. Bioad. Comp. Polym ., 3:370.
5.
Dumitriu, S. , M. Popa and M. Dumitriu.1989. "Polymeric Biomaterials as Enzyme and Drug Carriers. Part IV. Polymeric Drug Carrier Systems," J. Bioact. Comp. Polym., 4:151.
6.
Ueno, N. and M.F. Refojo.1983. "Ocular Pharmacology of Drug Release Devices in Controlled Drug Delivery," Clinical Applications , Vol. 2. S. D. Bruck, ed. Boca Raton: CRC Press, Inc., p. 90.
7.
Hosaka, S., H. Ozawa, H. Tanzawa, T. Kinitomo and R.L. Nichols.1983. "In vivo Evaluation of Ocular Inserts of Hydrogel Impregnated with Antibiotics for Trachoma Therapy," Biomaterials, 4:243.
8.
Dumitriu, S., C. Beldie, M. Popa and C. Dan.1987. Rom. Pat. 127892.
9.
Burns, D.T., G.H. Lloyd and J.W. Walker.1978. "The Calorimetric Determination of Neomycin ," LABP, 17:448.
